United States Biotechnology & Medical Research

ADARx Pharmaceuticals, Inc. (ADRX)

ADARx Pharmaceuticals experienced significant insider trading activity on September 28, 2026, with thirteen buy transactions totaling approximately $87.7 million. Five distinct entities, including OrbiMed Advisors and SR One Capital Management, acquired shares. These purchases occurred despite a 7.2% decline in stock price over the preceding ninety days, preceding any upcoming results financiers.
Ticker: ADRX Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
1.5
GORDON CARL L Non-Executive Director Large shareholder
Transaction date
Purchase
Price
489.36
Quantity 93,285 -27.9%
Value US$1,669,536
1.5
GORDON CARL L Non-Executive Director Large shareholder
Transaction date
Purchase
Price
290.82
Quantity 75,219 -8.7%
Value US$2,647,468
1.5
GORDON CARL L Non-Executive Director Large shareholder
Transaction date
Purchase
Price
380.77
Quantity 54,143 +37.3%
Value US$994,447
Chimovits Erez Non-Executive Director
Transaction date
Purchase
Price
17.00
Quantity 61,516 +0.7%
Value US$1,045,772
2.6
ORBIMED ADVISORS LLC Non-Executive Director Large shareholder
Transaction date
Purchase
Price
17.00
Quantity 588,235 New position
Value US$9,999,995
2.6
ORBIMED ADVISORS LLC Non-Executive Director Large shareholder
Transaction date
Purchase
Price
17.00
Quantity 61,516 +0.7%
Value US$1,045,772
2.6
ORBIMED ADVISORS LLC Non-Executive Director Large shareholder
Transaction date
Purchase
Price
17.00
Quantity 300,249 +2.1%
Value US$5,104,233
3.1
George Simeon Non-Executive Director Large shareholder
Transaction date
Purchase
Price
17.00
Quantity 592,593 New position
Value US$10,074,081
3.1
George Simeon Non-Executive Director Large shareholder
Transaction date
Purchase
Price
17.00
Quantity 414,814 +27.0%
Value US$7,051,838
3.1
George Simeon Non-Executive Director Large shareholder
Transaction date
Purchase
Price
17.00
Quantity 592,593 +11.9%
Value US$10,074,081
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-30 2026-09-28 B Purchase
1.5
GORDON CARL L
Non-Executive Director Large shareholder
93,285 -27.9%
489.36
US$1,669,536 		93,285 -27.9% 489.36 US$1,669,536
2026-09-30 2026-09-28 B Purchase
1.5
GORDON CARL L
Non-Executive Director Large shareholder
75,219 -8.7%
290.82
US$2,647,468 		75,219 -8.7% 290.82 US$2,647,468
2026-09-30 2026-09-28 B Purchase
1.5
GORDON CARL L
Non-Executive Director Large shareholder
54,143 +37.3%
380.77
US$994,447 		54,143 +37.3% 380.77 US$994,447
2026-09-30 2026-09-28 B Purchase
Chimovits Erez
Non-Executive Director
61,516 +0.7%
17.00
US$1,045,772 		61,516 +0.7% 17.00 US$1,045,772
2026-09-30 2026-09-28 B Purchase
2.6
ORBIMED ADVISORS LLC
Non-Executive Director Large shareholder
588,235 New position
17.00
US$9,999,995 		588,235 New position 17.00 US$9,999,995
2026-09-30 2026-09-28 B Purchase
2.6
ORBIMED ADVISORS LLC
Non-Executive Director Large shareholder
61,516 +0.7%
17.00
US$1,045,772 		61,516 +0.7% 17.00 US$1,045,772
2026-09-30 2026-09-28 B Purchase
2.6
ORBIMED ADVISORS LLC
Non-Executive Director Large shareholder
300,249 +2.1%
17.00
US$5,104,233 		300,249 +2.1% 17.00 US$5,104,233
2026-09-29 2026-09-28 B Purchase
3.0
SR ONE CAPITAL MANAGEMENT, LLC
Large shareholder
592,593 New position
17.00
US$10,074,081 		592,593 New position 17.00 US$10,074,081
2026-09-29 2026-09-28 B Purchase
3.0
SR ONE CAPITAL MANAGEMENT, LLC
Large shareholder
414,814 +27.0%
17.00
US$7,051,838 		414,814 +27.0% 17.00 US$7,051,838
2026-09-29 2026-09-28 B Purchase
3.0
SR ONE CAPITAL MANAGEMENT, LLC
Large shareholder
592,593 +11.9%
17.00
US$10,074,081 		592,593 +11.9% 17.00 US$10,074,081
2026-09-29 2026-09-28 B Purchase
3.1
George Simeon
Non-Executive Director Large shareholder
592,593 New position
17.00
US$10,074,081 		592,593 New position 17.00 US$10,074,081
2026-09-29 2026-09-28 B Purchase
3.1
George Simeon
Non-Executive Director Large shareholder
414,814 +27.0%
17.00
US$7,051,838 		414,814 +27.0% 17.00 US$7,051,838
2026-09-29 2026-09-28 B Purchase
3.1
George Simeon
Non-Executive Director Large shareholder
592,593 +11.9%
17.00
US$10,074,081 		592,593 +11.9% 17.00 US$10,074,081
Explore more

More insider trading research around ADARx Pharmaceuticals, Inc.

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America